Cancer Research UK’s Drug Development Office (DDO) has launched a vaccine trial to treat some forms of cancer caused by the Epstein Barr Virus (EBV).
A vaccine to prevent infection with a common herpes virus, the Epstein-Barr Virus (EBV), could help prevent 200,000 new cancers worldwide per year.
We cover the latest cancer research, including that funded by the charity. We also highlight other relevant material, debunk myths and media scares, and provide links to other helpful resources.
Text from Cancer Research UK Science blog by Cancer Research UK, is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License.